As the announcement says, LGO didn't submit their EOY report in time to the ASX. Therefore the ASX has no way of knowing if they are in a position to continue trading.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling